
Iterum Therapeutics PLC (ITRM)
NASDAQ
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -100.041 | -79.827 | -106.558 | -166.847 | -177.668 | -147.326 | -55.16 | -82.437 |
Return on Equity (%) | -118.793 | -94.611 | -138.695 | -454.477 | 135.438 | 56347.077 | -111.643 | -355.353 |
Return on Invested Capital (%) | -124.592 | -100.162 | -129.708 | -422.364 | 111.963 | -102.04 | -44.641 | -141.204 |
Operating Margin (%) | N/A | -5701.181 | -8763.867 | -275202.703 | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | -5788.583 | -8867.204 | -278729.73 | N/A | N/A | N/A | N/A |
Book Value Per Share | 54.886 | 95.627 | 4.99 | -1.798 | -1.023 | 0.256 | N/A | -0.474 |
Earnings Per Share | -32.6 | -71.201 | -5.369 | -7.069 | -1.052 | -0.501 | N/A | -2.843 |
Cash Per Share | 60.07 | 20.545 | 3.104 | 0.329 | 0.294 | 0.15 | N/A | 0.45 |
Working Capital Per Share | 52.404 | 89.702 | 5.627 | -1.732 | -0.409 | 0.385 | N/A | 0.895 |
Operating Profit Per Share | 0.019 | 1.753 | 0.088 | 0.016 | 0.011 | 0.001 | N/A | 0.006 |
EBIT Per Share | -32.327 | -70.126 | -5.336 | -7.039 | -1.037 | -0.497 | N/A | -2.797 |
EBITDA Per Share | -32.327 | -70.126 | -5.336 | -7.039 | -1.037 | -0.497 | N/A | -2.797 |
Free Cash Flow Per Share | -32.6 | -69.392 | -5.372 | -7.069 | -1.052 | -0.512 | N/A | -2.971 |
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 413k | 413k | 14,35M | 14,59M | 49,43M | 182,78M | N/A | 13,5M |
Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Actions en circulation | N/A | 12,6M | 13,03M | 13,04M | 13,5M | 16,47M | 16,58M | 22,71M |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 46,34M |
Ratio cours/bénéfice | -1,23 |
Ratio prix/ventes | 570,83 |
Ratio prix/liquidités | 7,8 |
Ratio prix/valeur comptable | -7,4 |
Rendement de dividende | - |
Actions en circulation | 34,58M |
Volume moyen (1 semaine) | 271,29k |
Volume moyen (1 mois) | 296,43k |
Variation sur 52 semaines | -8,84% |
Plus haut sur 52 semaines | 3,02 |
Plus bas sur 52 semaines | 0,808 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales